Jaguar HealthJAGX +1.87%22 Operating Margin % is 50.29% as of Mar. 2026. GuruFocus rates JAGX with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 945 Biotechnology companies, Jaguar Health ranks better than 50.16% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Jaguar Health's Operating Income for the
three
months ended in Mar. 2026 was $10.18 Mil. Jaguar Health's Revenue for the
three
months ended in Mar. 2026 was $20.25 Mil. Therefore, Jaguar Health's Operating Margin % for the quarter that ended in Mar. 2026 was 50.29%.
Good Sign:
Jaguar Health Inc operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Jaguar Health's Operating Margin % or its related term are showing as below:
JAGX'
s Operating Margin % Range Over the Past 10 Years
Min: -9567.61 Med: -369.69 Max: -86.33
Current: -86.33
JAGX's Operating Margin % is ranked better than 50.16% of 945
companies
in the Biotechnology industry
Industry Median: -86.89
vs JAGX: -86.33
Jaguar Health's 5-Year Average Operating Margin % Growth Rate was 2.20% per year.
Jaguar Health's Operating Income for the
three
months ended in Mar. 2026 was $10.18 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $-25.51 Mil.
Jaguar Health (NAS:JAGX) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Jaguar Health Operating Margin % Related Terms
Jaguar Health Operating Margin % Historical Data
* Premium members only.
The historical data trend for Jaguar Health's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JAGX vs BBLG, VBIO, PKTX: Operating Margin % Comparison
For the Biotechnology subindustry, Jaguar Health's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jaguar Health Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jaguar Health's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Jaguar Health's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Jaguar Health's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaguar Health (JAGX) has a Operating Margin % of 50.29% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Jaguar Health and its competitors. According to the industry distribution chart, Jaguar Health ranks #471 out of 945 companies in the Biotechnology industry, placing it in the top 49.8%.
Is Jaguar Health's Operating Margin % too high?
Jaguar Health's current Operating Margin % is 50.29%. Based on the distribution chart, Jaguar Health ranks #471 out of 945 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Jaguar Health has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Jaguar Health's Operating Margin % compare to BBLG and VBIO?
According to the Biotechnology industry distribution chart, Jaguar Health ranks #471 out of 945 companies for Operating Margin %. This puts Jaguar Health in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Jaguar Health and its competitors. Jaguar Health's current Operating Margin % is 50.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaguar Health stock overvalued right now?
Jaguar Health (JAGX) has a current Operating Margin % of 50.29%. The current Operating Margin % is 50.29%. Jaguar Health's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Jaguar Health (JAGX), the current Operating Margin % is 50.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
22GF Score
Get the complete analysis for JAGX
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JAGX has been successfully added to your 
